Article Text
Letter
High-dose ustekinumab for severe childhood deficiency of interleukin-36 receptor antagonist (DITRA)
Statistics from Altmetric.com
Footnotes
NB and RC contributed equally.
JF and MG contributed equally.
Contributors NB, RC, JF and MG analysed the data and wrote the manuscript. GMV, MdG, FM and PP followed the patient, collected the data and approved the manuscript. AG and IC performed the genetic analysis and approved the manuscript.
Competing interests None declared.
Patient consent Guardian consent.
Ethics approval G Gaslini IRCCS Ethics Board.
Provenance and peer review Not commissioned; externally peer reviewed.